Compare ARCT & SMBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARCT | SMBK |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.1M | 636.5M |
| IPO Year | N/A | N/A |
| Metric | ARCT | SMBK |
|---|---|---|
| Price | $6.84 | $37.27 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | $38.44 | ★ $38.63 |
| AVG Volume (30 Days) | ★ 627.7K | 106.1K |
| Earning Date | 11-10-2025 | 01-20-2026 |
| Dividend Yield | N/A | ★ 0.86% |
| EPS Growth | N/A | ★ 41.99 |
| EPS | N/A | ★ 2.74 |
| Revenue | $97,601,000.00 | ★ $188,204,000.00 |
| Revenue This Year | N/A | $22.00 |
| Revenue Next Year | N/A | $9.67 |
| P/E Ratio | ★ N/A | $13.50 |
| Revenue Growth | N/A | ★ 18.22 |
| 52 Week Low | $5.85 | $26.31 |
| 52 Week High | $24.17 | $40.08 |
| Indicator | ARCT | SMBK |
|---|---|---|
| Relative Strength Index (RSI) | 47.68 | 46.76 |
| Support Level | $6.02 | $36.21 |
| Resistance Level | $6.75 | $37.84 |
| Average True Range (ATR) | 0.30 | 0.90 |
| MACD | 0.16 | -0.27 |
| Stochastic Oscillator | 69.87 | 25.21 |
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.